1[1]Takahashi T,Ozawa K,Takahashi K,et al.Susceptibility of human erythropoietic cell to B19 parvovirus in vitro increases with differentiation.Blood,1990;75(3):603
2[2]Brown KE,Anderson SM,Young NS.Erythrocyte P antigen:cellular receptor for B19 parvovirus.Science,1993;262(5130):114
3[3]Hemauer A,Von Poblotzki A,Grigler A,et al.Sequence variability among different parvovirus B19 isolates.J Gen virol,1996;77(pt8):1781
4[4]Umene K,Nunone T.A new genome type of human parvovirus B19 present in sera of patients with encephalopathy.J Gen Virol,1995;76(11):2645
5[5]Okumura A,Ichikawa T.Aseptic meningitis caused by human parvovirus B19.Arch Dis Child,1993;68(6):784
6[6]Suzuki N,Terada S,Inoue M.Neonatal meningitis with human parvovirus B19 infection.Arch Child Fetal Neonatal Ed,1995;733(3):196
7[7]Heeguard ED,Peterslund NA,Hornsleth A.Parvovirus B19 infection associated with encephalitis in a patient suffering from malignant lymphoma.Scand J Infect Dis,1995;27(6):631
8[8]Cassinotti P,Schultze D,Schlageter P,et al.Persistent human parvovirus B19 infection following an acute infection with meningits in an immunocompetent patient.Eur J Clin Microlbiol Infect Dis,1993;12(9):701
